Are peptides really better than steroids? We fact-checked

What did @astrid.thefitdietitian actually say?

The creator, speaking with what sounds like a guest clinician, made several distinct claims worth separating out. First, that peptides should only be prescribed by licensed clinicians, not "gurus." Second, and this is the one that should make your eyebrows move, that peptides "can have more side effects than anabolic steroids or other medications." Third, that poor blood flow to areas of stubborn body fat and cellulite creates an oxygen deficit that prevents fat cells from releasing energy properly. Finally, that hormonal contraceptives are functionally "synthetic HRT," a framing that will not win friends at peptide clinics.

To be fair, the transcript is disjointed. The speaker seems to be mid-conversation, and several statements lack context. That makes some of this harder to evaluate than a scripted video would be. But the claims are specific enough to check.

Does the science back this up?

The side-effect comparison to anabolic steroids is the most eyebrow-raising claim here, and the science does not straightforwardly support it. Anabolic steroids have a well-documented, decades-long safety record in the sense that we know exactly how bad they can be: hepatotoxicity, cardiovascular remodeling, endocrine suppression, and psychiatric effects. Peptides lack that depth of long-term human safety data entirely.

On the cellulite and blood flow mechanism, there is something real underneath the claim. Research does show that areas with subcutaneous fat and cellulite have reduced microcirculation and lower oxygen tension compared to surrounding tissue. A 2006 paper by Rawlings (International Journal of Cosmetic Science) documented this microvascular component. But connecting that directly to mitochondrial dysfunction and fat cell "release" is several inferential steps further than the data actually goes. The speaker even catches herself: "Am I making this up?" That self-awareness is worth crediting, but the claim still landed on an Instagram reel without the caveat doing much work.

On the hormonal contraceptive point, the chemistry is not wrong. Synthetic progestins and estrogens are exogenous hormones. Whether framing them as "HRT" is clinically accurate or useful is a different question.

What did they get right and wrong?

Right: The point about clinician oversight is correct and genuinely important. The regulatory reality is that peptides classified as drugs in many jurisdictions require a prescription from a licensed prescriber, and compounds sourced outside that framework carry serious contamination and dosing risks. Kudos for saying it plainly.

Wrong, or at least unsupported: The side-effect comparison to anabolic steroids is framed as if peptides are the riskier category. That is not established. What is true is that the long-term safety profile of many research peptides, particularly those like BPC-157 and TB-500 that have not completed Phase III trials in humans, is simply unknown. Unknown is not the same as worse than steroids. It means we do not have the data. Presenting unfounded claims of greater risk, without citations, to a 10,000-view audience is still misinformation even if it comes from a place of caution.

The cellulite mechanism is creative but speculative. The creator seems to sense this herself. The biology of stubborn fat involves hormonal receptor density, primarily alpha-2 adrenergic receptor concentration, more than oxygen alone (Lafontan and Berlan, 1993, Journal of Lipid Research). Attributing it primarily to blood flow and mitochondrial oxygen access is an oversimplification.

What should you actually know?

Peptides are a genuinely heterogeneous category. Some, like creatine, have strong safety records. Others being discussed in optimization communities, like CJC-1295 or ipamorelin, have limited long-term human trial data. The FDA has moved to restrict several compounded peptides in recent years, which tells you something about where the regulatory risk sits.

If you are considering peptide therapy, the most evidence-based step is straightforward: see a licensed clinician who can review your blood work, confirm a clinical indication, and source compounds through a licensed compounding pharmacy operating under state board oversight. "Guru" sourcing is not just legally risky. It is a quality control problem. Independent testing of research peptides sold online has found significant variation in actual peptide content (Kicman et al., 2009, British Journal of Sports Medicine).

The comparison to steroids as a safety benchmark also deserves scrutiny. Anabolic steroids are not a safe baseline. Using them as the bar clears is not the reassurance it might sound like on a podcast.